More than one in two Irish parents say their child missed schools days in the past year due to flu or flu-like symptoms with ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Moderna stock rises as Q3 revenue beats estimates at $1.83 billion, driven by strong U.S. COVID-19 vaccine sales. EPS of $0.03 exceeds expectations.

This strategic move positions BioVaxys alongside major players like AstraZeneca and Genentech, enhancing its role in developing priority vaccine programs. For further insights into TSE:BIOV stock, ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

The 868-page report of the official inquiry into Australia’s Covid-19 response, like the inquiry itself, is not fit for ...

TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck cancer ...

Tickets are available – and registration will be open right up until the day of the event – for the 2024 Protein Science in ...

In 2021, the family pledged £50million to Oxford university for a new Poonawalla Vaccines Research Building, having manufactured hundreds of millions of doses of the Oxford/AstraZeneca vaccine.

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...

This column, forecasting a Trump election win, last week expressed surprise so many news consumers remain loyal to media ...

AstraZeneca may have exited the COVID-19 vaccine market, but it is still hoping to protect vulnerable patients with its antibody sipavibart for pre-exposure prophylaxis (PrEP). The drugmaker said ...